Oops: Elsevier journal publishes paper citing paper it promised to retract two months ago

elsevierJournal publishers can be agonizingly slow when it comes to officially retracting a paper.

Here’s a prime example of the consequences of that bureaucratic foot-dragging: Ten months after being told that Fazlurrahman Khan had fabricated his data, and two months after announcing two of Khan’s papers would be retracted from two of its journals, Elsevier still has not retracted either paper.

Worse, at least one of the papers, “Degradation of 2,4-dinitroanisole (DNAN) by metabolic cooperative activity of Pseudomonas sp. strain FK357 and Rhodococcus imtechensis strain RKJ300,” in the journal Chemosphere, has been cited since the announcement was made. In fact, the paper was published in Journal of Hazardous Materials, the Elsevier journal that is dragging its feet retracting another of Khan’s papers, “Aerobic degradation of 4-nitroaniline (4-NA) via novel degradation intermediates by Rhodococcus sp. strain FK48.”

Jim Spain, in whose lab Khan worked at Georgia Tech, reached out to us to express his concerns with this timeline: Continue reading Oops: Elsevier journal publishes paper citing paper it promised to retract two months ago

Contrary to reports, Lancet not retracting controversial letter to people of Gaza

logo_lancetDespite the claims of a widely circulated news report today, The Lancet has no plans to retract a controversial open letter to the people of Gaza that has drawn criticism since being published in August.

The Jewish Telegraphic Agency (JTA) reported this morning: Continue reading Contrary to reports, Lancet not retracting controversial letter to people of Gaza

Nature, facing “considerable rise” in retractions, blames lawyers for opaque and delayed notices

nature oct coverNature, as we and others have noticed, has had what Paul Knoepfler referred to as a “torrent” of retractions in the past two years. That torrent — 13 research papers — has prompted a welcome and soul-searching editorial, as it did in 2010 when the journal had what it called an “unusually large number” of 4.

As the editors write this week in “Retraction challenges:” Continue reading Nature, facing “considerable rise” in retractions, blames lawyers for opaque and delayed notices

Double dipping on trial data topples 17-year-old macular degeneration article

redjournalThe authors of a 1997 paper on macular degeneration have lost the article after readers noticed uncanny similarities with a 1996 publication from several of the same authors.

The retracted article, “Radiation therapy for macular degeneration: Technical considerations and preliminary results,” appeared in the International Journal of Radiation Oncology*Biology*Physics — otherwise known as the “Red Journal.” The first author, Luther W. Brady, is a leading U.S. oncologist.

According to the retraction notice: Continue reading Double dipping on trial data topples 17-year-old macular degeneration article

PubPeer Selections: Sniffing at a dog poop paper; how grants should be distributed

Here’s another installment of PubPeer Selections:pubpeer Continue reading PubPeer Selections: Sniffing at a dog poop paper; how grants should be distributed

Author of alcohol paper retracted for plagiarism defends copy-and-paste strategy

nmlogoThe authors of a paper retracted for plagiarism of a popular website have decided not to take the charges — which they don’t contest — lying down.

Here’s the notice for “Alcohol consumption and hormonal alterations related to muscle hypertrophy: a review,” which appeared in Nutrition & Metabolism, a BioMed Central title: Continue reading Author of alcohol paper retracted for plagiarism defends copy-and-paste strategy

Critics of Poldermans’ work baffled by NEJM stance on DECREASE papers

EBPOM_00219_M3
Don Poldermans

A pair of researchers who have been calling for the retraction of two papers by cardiology researcher Don Poldermans say the New England Journal of Medicine is  “not justified” “disappointing” in its refusal to pull the articles.

A little background: Poldermans resigned from Erasmus University in 2011 after having been accused of misconduct. Last week, we reported that the European Heart Journal had issued an expression of concern for a 2001 article on which he was first author.

The New England Journal of Medicine added editor’s notes to two of Poldermans’ articles. But as Larry Husten at Forbes reports, the journal has no intention of retracting the papers: Continue reading Critics of Poldermans’ work baffled by NEJM stance on DECREASE papers

It’s happened again: Researcher appears to have peer reviewed his own paper

bmc sys bioAlthough it shocks some observers every time, we’ve reported on the retractions of more than 100 papers pulled because authors managed to do their own peer review.

Apparently, it’s happened again.

Here’s a retraction notice in BMC Systems Biology for “Predicting new molecular targets for rhein using network pharmacology,” by  Aihua Zhang, Hui Sun, Bo Yang and Xijun Wang:

Continue reading It’s happened again: Researcher appears to have peer reviewed his own paper

Molecular Vision retracts three papers from University of Georgia group with error-ridden images

newmvlogoMolecular Vision has issued “full retractions” for a trio of articles by a group of eye researchers. All of the articles were led by Azza El-Remessy, director of the University of Georgia College of Pharmacy’s clinical and therapeutic graduate program.

As much as that is, there might be more still with this case.

The first paper, from 2000, was titled “Regulation of interphotoreceptor retinoid-binding protein (IRBP) gene expression by cAMP in differentiated retinoblastoma cell.” Its abstract states: Continue reading Molecular Vision retracts three papers from University of Georgia group with error-ridden images

Publisher issues statement of concern about HIV denial paper, launches investigation

frontiers phThe publisher Frontiers has issued a Statement of Concern about a paper denying that HIV causes AIDS, and has launched an investigation into how the paper was published in the first place.

The paper, “Questioning the HIV-AIDS hypothesis: 30 years of dissent,” is written by Patricia Goodson of Texas A&M University and was published on September 23 in Frontiers in Public Health. As Tara Smith, who blogged about the paper yesterday, notes: Continue reading Publisher issues statement of concern about HIV denial paper, launches investigation